Clinical and immunological analysis of cutaneous leishmaniasis before and after different treatments

Journal of Parasitology Research

Volumn 2013, Issue , 2013, Pages

  O'Daly, José A ^a,b   Spinetti, Humberto M ^b   Gleason, Joe ^a   Rodríguez, María B ^b  

^a Astralis Ltd   (United States)

^b INSTITUTO VENEZOLANO DE INVESTIGACIONES CIENTÍFICAS   (Venezuela)

Author keywords

[No Author keywords available]

Indexed keywords

MEGLUMINE ANTIMONATE; PARASITE ANTIBODY; PROTOZOAL VACCINE; TOSYLLYSYL CHLOROMETHYL KETONE; TRITON X 114;

ADULT; AMASTIGOTE; ANTIBODY DETECTION; ARTICLE; CHILD; CLINICAL TRIAL (TOPIC); CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DENSITOMETRY; DIAGNOSTIC VALUE; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMORAL IMMUNITY; IMMUNOBLOTTING; INFECTION PREVENTION; LEISHMANIA; LEISHMANIA BRAZILIENSIS; LEISHMANIA CHAGASI; LEISHMANIA VENEZUELENSIS; MAJOR CLINICAL STUDY; MALE; OPTICAL DENSITY; PRESCHOOL CHILD; PRIMARY INFECTION; PRIORITY JOURNAL; REMISSION; SECONDARY INFECTION; SKIN LEISHMANIASIS; TREATMENT DURATION;

EID: 84880155958     PISSN: 20900023     EISSN: 20900031     Source Type: Journal    
DOI: 10.1155/2013/657016     Document Type: Article

References (45)

1. Berman J. D., Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clinical Infectious Diseases 1997 24 4 684 703 2-s2.0-0030940539
2. Desjeux P., Leishmaniasis: current situation and new perspectives. Comparative Immunology, Microbiology and Infectious Diseases 2004 27 5 305 318 2-s2.0-3042555141 10.1016/j.cimid.2004.03.004
3. Nakkash-Chmaisse H., Makki R., Nahhas G., Knio K., Nuwayri-Salti N., Detection of Leishmania parasites in the blood of patients with isolated cutaneous leishmaniasis. International Journal of Infectious Diseases 2011 15 7 e491 e494 2-s2.0-79959196984 10.1016/j.ijid.2011.03.022
4. Awasthi A., Mathur R. K., Saha B., Immune response to Leishmania infection. Indian Journal of Medical Research 2004 119 6 238 258 2-s2.0-4043148418
5. Reiner N. E., Ng W., Ma T., McMaster W. R., Kinetics of γ interferon binding and induction of major histocompatibility complex class II mRNA in Leishmania-infected macrophages. Proceedings of the National Academy of Sciences of the United States of America 1988 85 12 4330 4334 2-s2.0-0008238929
6. Reiner N. E., Ng W., McMaster W. R., Parasite-accessory cell interactions in murine leishmaniasis. II. Leishmania donovani suppresses macrophage expression of class I and class II major histocompatibility complex gene products. Journal of Immunology 1987 138 6 1926 1932 2-s2.0-0023151617
7. Handman E., Leishmaniasis: current status of vaccine development. Clinical Microbiology Reviews 2001 14 2 229 243 2-s2.0-0035067363 10.1128/CMR.14.2.229-243.2001
8. Brelaz M. C. A., De Oliveira A. P., De Almeida A. F., De Assis Souza M., Medeiros Â. C. R., De Brito M. E. F., Pereira V. R. A., Antigenic fractions of Leishmania (Viannia) braziliensis: the immune response characterization of patients at the initial phase of disease. Parasite Immunology 2012 34 4 236 239 2-s2.0-84857975173 10.1111/j.1365-3024.2012.01351.x
9. Altes J., Salas A., Riera M., Udina M., Galmes A., Balanzat J., Ballesteros A., Buades J., Salva F., Villalonga C., Visceral leishmaniasis: another HIV-associated opportunistic infection? Report of eight cases and review of the literature. AIDS 1991 5 2 201 207 2-s2.0-0025980312
10. Scaglia M., Villa M., Gatti S., Fabio F., Cutaneous leishmaniasis in acquired immunodeficiency syndrome. Transactions of the Royal Society of Tropical Medicine and Hygiene 1989 83 3 338 339 2-s2.0-0024661802
11. Casadevall A., Antibody-mediated protection against intracellular pathogens. Trends in Microbiology 1998 6 3 102 107 2-s2.0-0031916168 10.1016/S0966-842X(98)01208-6
12. Ravindran R., Ali N., Progress in vaccine research and possible effector mechanisms in visceral leishmaniasis. Current Molecular Medicine 2004 4 6 697 709 2-s2.0-4444350068 10.2174/1566524043360212
13. Nagill R., Kaur S., Vaccine candidates for leishmaniasis: a review. International Immunopharmacology 2011 11 10 1464 1488 2-s2.0-80053251597 10.1016/j.intimp.2011.05.008
14. Zügel U., Kaufmann S. H. E., Role of heat shock proteins in protection from and pathogenesis of infectious diseases. Clinical Microbiology Reviews 1999 12 19 39
15. O'Daly J. A., Lezama R., Rodríguez P. J., Antigens from Leishmania amastigotes induced clinical remission of psoriasis. Archives of Dermatological Research 2009 301 1 13
16. O'Daly J. A., Lezama R., Gleason J., Isolation of Leishmania amastigote protein fractions which induced lymphocyte stimulation and remission of psoriasis. Archives of Dermatological Research 2009 301 6 411 427 2-s2.0-68149165489 10.1007/s00403-009-0940-z
17. O'Daly J. A., Gleason J., Lezama R., Rodriguez P. J., Silva E., Indriago N. R., Antigens from Leishmania amastigotes inducing clinical remission of psoriatic arthritis. Archives of Dermatological Research 2011 303 6 399 415 2-s2.0-79960704539 10.1007/s00403-011-1133-0
18. O'Daly J. A., psoriatic disease: a systemic pathology, structured by psoriasis, psoriatic arthritis and comorbidities. The Journal of Clinical Rheumatology and Musculoskeletal Medicine 2011 2 1 11
19. O'Daly J. A., Gleason J. P., Peña G., Colorado I., Purified proteins from Leishmania amastigotes-induced delayed type hypersensitivity reactions and remission of collagen-induced arthritis in animal models. Archives of Dermatological Research 2010 302 8 567 581 2-s2.0-77958081962 10.1007/s00403-009-1026-7
20. O'Daly J. A., O'Daly J. A., Psoriasis a systemic disease beyond the skin, as evidenced by psoriatic arthritis and many comorbidities. Clinical remission with a Leishmania amastigotes vaccine, a serendipity finding. PsoriAsis A Systemic Disease 2012 Rijeka, Croatia InTech 1 56
21. O'Daly J. A., Rodríguez M. B., Differential growth requirement of several Leishmania spp in chemically defined culture media. Acta Tropica 1988 45 109 126
22. Sokal J. E., Measurement of delayed skin test responses. The New England Journal of Medicine 1975 293 10 501 502 2-s2.0-0016842811
23. O'Daly J. A., Carrasco H., Fernandez V., Rodríguez M. B., Comparison of chagasic and non-chagasic myocardiopathies by ELISA and immunoblotting with antigens of Trypanosoma cruzi and Trypanosoma rangeli. Acta Tropica 1994 56 4 265 287 2-s2.0-0028212136 10.1016/0001-706X(94)90099-X
24. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J., Protein measurement with the Folin phenol reagent. The Journal of Biological Chemistry 1951 193 1 265 275 2-s2.0-71849104860
25. Smith P. K., Krohn R. I., Hermanson G. T., Measurement of protein using bicinchoninic acid. Analytical Biochemistry 1985 150 1 76 85 2-s2.0-0022186670
26. O'Daly J. A., Cabrera Z., Immunization of hamsters with TLCK-killed parasites induces protection against Leishmania infection. Acta Tropica 1986 43 3 225 236 2-s2.0-0022775573
27. Nunes V. L. B., Dorval M. E. C., Oshiro E. T., Noguchi R. C., Arao L. B., Filho G. H., Espindola M. A., Cristaldo G., Da Rocha H. C., Serafini L. N., Santos D., Epidemiological study on tegumental leishmaniasis (TL) in the Municipality of Corguinho, Mato Grosso do Sul State, Brazil. Study on human population. Revista da Sociedade Brasileira de Medicina Tropical 1995 28 3 185 193 2-s2.0-0029091112
28. Davies C. R., Llanos-Cuentas E. A., Pyke S. D. M., Dye C., Cutaneous leishmaniasis in the Peruvian Andes: an epidemiological study of infection and immunity. Epidemiology and Infection 1995 114 2 297 318 2-s2.0-0028912512
29. Armijos R. X., Weigel M. M., Izurieta R., Racines J., Zurita C., Herrera W., Vega M., The epidemiology of cutaneous leishmaniasis in subtropical Ecuador. Tropical Medicine and International Health 1997 2 2 140 152 2-s2.0-0030621315
30. Choudhury R., Das P., Bhaumik S. K., De T., Chakraborti T., In situ immunolocalization and stage-dependent expression of a secretory serine protease in Leishmania donovani and its role as a vaccine candidate. Clinical and Vaccine Immunology 2010 17 4 660 667 2-s2.0-77950646645 10.1128/CVI.00358-09
31. Jain R., Ghoshal A., Mandal C., Shaha C., Leishmania cell surface prohibitin: role in host-parasite interaction. Cellular Microbiology 2010 12 4 432 452 2-s2.0-77954274538 10.1111/j.1462-5822.2009.01406.x
32. Carvalho E. M., Filho D. C., Bacellar O., Almeida R. P., Lessa H., Rocha H., Characterization of the immune response in subjects with self-healing cutaneous Leishmaniasis. American Journal of Tropical Medicine and Hygiene 1995 53 3 273 277 2-s2.0-0029147745
33. Mansueto P., Pepe I., Seidita A., Scozzari F., Vitale G., Arcoleo F., Elvira I., Cillari E., Rini G. B., Napoli N., Di Rosa S., Mansueto S., Di Fede G., Significance of persistence of antibodies against Leishmania infantum in sicilian patients affected by acute visceral leishmaniasis. Clinical and Experimental Medicine 2011 12 127 132 2-s2.0-79959537068 10.1007/s10238-011- 0150-9
34. Cataldo J. I., de Queiroz Mello F. C., Mouta-Confort E., de Fátima Madeira M., de Oliveira Schubach A., Genestra M. D. S., Ribeiro F. C., Moreira-Venâncio C. D. F., Passos S. R. L., Immunoenzymatic assay for the diagnosis of American tegumentary leishmaniasis using soluble and membrane-enriched fractions from infectious Leishmania (Viannia) braziliensis. Journal of Clinical Laboratory Analysis 2010 24 5 289 294 2-s2.0-77957268390 10.1002/jcla.20402
35. Buxbaum L. U., A detrimental role for IgG and FcgammaR in Leishmania mexicana infection. Immunologic Research 2008 42 1-3 197 209 2-s2.0-61849184975 10.1007/s12026-008-8074-5
36. Halstead S. B., Mahalingam S., Marovich M. A., Ubol S., Mosser D. M., Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes. The Lancet Infectious Diseases 2010 10 10 712 722 2-s2.0-77957160633 10.1016/S1473-3099(10)70166-3
37. Fruth U., Solioz N., Louis J. A., Leishmania major interferes with antigen presentation by infected macrophages. Journal of Immunology 1993 150 5 1857 1864 2-s2.0-0027270092
38. + T cells. European Journal of Immunology 1996 26 12 3163 3169 2-s2.0-0029799686
39. O'Daly J. A., Garcia P., Rodriguez M. B., Ovalles T., Leishmania promastigotes secreted/excreted products, characterization and protection of BALB/c mice against virulent amastigotes by vaccination. The Annals of Infectious Diseases 2012 1 1 1 12
40. Kemp M., Hansen M. B., Theander T. G., Recognition of Leishmania antigens by T lymphocytes from nonexposed individuals. Infection and Immunity 1992 60 6 2246 2251 2-s2.0-0026638389
41. O'Daly J. A., Rodriguez B., Ovalles T., Pelaez C., Lymphocyte subsets in peripheral blood of patients with psoriasis before and after treatment with leishmania antigens. Archives of Dermatological Research 2010 302 2 95 104 2-s2.0-77449146937 10.1007/s00403-009-0992-0
42. Goto Y., Bhatia A., Raman V. S., Liang H., Mohamath R., Picone A. F., Vidal S. E. Z., Vedvick T. S., Howard R. F., Reed S. G., KSAC, the first defined polyprotein vaccine candidate for visceral leishmaniasis. Clinical and Vaccine Immunology 2011 18 7 1118 1124 2-s2.0-79960130905 10.1128/CVI.05024-11
43. Boyman O., Conrad C., Dudli C., Kielhorn E., Nickoloff B. J., Nestle F. O., Activation of dendritic antigen-presenting cells expressing common heat shock protein receptor CD91 during induction of psoriasis. British Journal of Dermatology 2005 152 6 1211 1218 2-s2.0-21644439478 10.1111/j.1365-2133.2005. 06701.x
44. Rajaiah R., Moudgil K. D., Heat-shock proteins can promote as well as regulate autoimmunity. Autoimmunity Reviews 2009 8 5 388 393 2-s2.0-61549130869 10.1016/j.autrev.2008.12.004
45. Rambukkana A., Das P. K., Witkamp L., Yong S., Meinardi M. M. H. M., Bos J. D., Antibodies to mycobacterial 65-kDa heat shock protein and other immunodominant antigens in patients with psoriasis. Journal of Investigative Dermatology 1993 100 1 87 92 2-s2.0-0027492307